US5858746A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Gels for encapsulation of biological materials
Assignee: The University of Texas System
•
Filing: 1995-01-25
•
Granted: 1999-01-12
•
Expires: 2015-01-25
Abstract
Abstract Water soluble macromers are modified by addition of free radical polymerizable groups, such as those containing a carbon-carbon double or triple bond, which can be polymerized under mild conditions to encapsulate tissues, cells, or biologically active materials. The polymeric materials are particularly useful as tissue adhesives, coatings for tissue lumens including blood vessels, coatings for cells such as islets of Langerhans, coatings, plugs, supports or substrates for contact with biological materials such as the body, and as drug delivery devices for biologically active molecules.
Inventors
- 👤 Jeffrey A. Hubbell
- 👤 Chandrashekhar P. Pathak
- 👤 Amarpreet S. Sawhney
- 👤 Neil P. Desai
- 👤 Jennifer L. Hill
- 👤 Syed F. A. Hossainy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:25
CPC Classifications
C; C12; C12N; C12N11/00; C12N11/02; C12N11/04; A; A61; A61K; A61K38/00; A61K38/16; A61K38/41; A61K38/42; A61K38/43; A61K38/44; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/645; A61K47/69; A61K47/6903; A61K47/6921; A61K47/6927; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K9/1641; A61K9/1647; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5026; A61K9/5031; A61K9/5073; A61L; A61L24/00; A61L24/001; A61L24/0031; A61L24/0042; A61L24/04; A61L24/046; A61L26/00; A61L26/0009; A61L26/0019; A61L27/00; A61L27/28; A61L27/34; A61L27/36; A61L27/3683; A61L27/38; A61L27/50; A61L27/52; A61L29/00; A61L29/08; A61L29/085; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/145; A61L31/148; B; B82; B82Y; B82Y5/00; C08; C08B; C08B37/00; C08B37/0006; C08B37/0024; C08B37/0027; C08B37/003; C08B37/006; C08B37/0063; C08B37/0072; C08B37/0084; C08F; C08F290/00; C08F290/02; C08F290/06; C08F290/062; C08F290/08; C08F290/10; C08F291/00; C09; C09D; C09D153/00; C12N5/00; C12N5/0012; C12N5/06; C12N5/0602; C12N5/0676; C12N5/0677; A61K35/00; A61K35/12; A61K2035/126; A61K2035/128; C12N2533/00; C12N2533/30; C12N2533/32; C12N2533/40; C12N2533/70; C12N2533/74; Y; Y10; Y10S; Y10S530/00; Y10S530/81; Y10S530/812; Y10S530/813; Y10S530/815; Y10S530/817; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984; Y10T428/2985; Y10T428/2987; Y10T428/2989
Claims Analysis
Total Claims: 34
Claim 1
Independent Claim
106 words
A method for encapsulating, sealing, plugging, or supporting of mammalian cells, cell aggregates, or cell tissue comprising: a) applying (i) a water soluble biocompatible macromer comprising at least two free radical-polymerizable substituents, wherein the macromer is non-toxic and has a molecular weight of at least 400, and (ii) a non-toxic free radical polymerization initiator selected from the group consisting of visible light or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free radical initiators, benzoyl peroxide, potassium persulfate and ammonium persulfate; to (iii) mammalian cells, cell aggregates, or cell tissue; and b) exposing the mixture to an activating agent to cause polymerization of the macromers.
Claim 2
Independent Claim
106 words
A method for encapsulating, sealing, plugging, or supporting of mammalian cells, cell aggregates, or cell tissue comprising: a) applying (i) a water soluble biocompatible macromer comprising at least two free radical-polymerizable substituents, wherein the macromer is non-toxic and has a molecular weight of at least 400, and (ii) a non-toxic free radical polymerization initiator selected from the group consisting of visible light or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free radical initiators, benzoyl peroxide, potassium persulfate and ammonium persulfate; to (iii) mammalian cells, cell aggregates, or cell tissue; and b) exposing the mixture to an activating agent to cause polymerization of the macromers.
Claim 3
Dependent Claim
12 words
The method of claim 1 wherein the biological material is cell tissue.
Claim 4
Dependent Claim
40 words
The method of claim 1 further comprising biologically active molecules selected from the group consisting of peptides of less than one hundred amino acids, proteins of one hundred or more amino acids, polysaccharides, nucleic acids, organic drugs, and inorganic drugs.
Claim 5
Dependent Claim
16 words
The method of claim 1 wherein the free-radical polymerizable substituents contain carbon-carbon double or triple bonds.
Claim 6
Dependent Claim
17 words
The method of claim 1 where a non-toxic catalyst or accelerator is added to the mixing step.
Claim 7
Dependent Claim
42 words
The method of claim 1 wherein the water soluble macromer is selected from the group consisting of poly(ethylene glycol), poly(ethylene oxide), poly(vinyl alcohol), poly(vinylpyrrolidone), poly(ethyloxazoline), poly(amino acid), polysaccharides, proteins, or a block or random copolymer thereof comprising two or more polymerizable substituents.
Claim 8
Dependent Claim
37 words
The method of claim 6 wherein the polysaccharide is selected from the group consisting of alginate, hyaluronic acid, chondroitin sulfate, dextran, dextran sulfate, heparin, heparin sulfate, heparan sulfate, chitosan, gellan gum, xanthan gum, guar gum, and K-carrageenan.
Claim 9
Dependent Claim
19 words
The method of claim 6, wherein the protein is selected from the group consisting of gelatin, collagen and albumin.
Claim 10
Dependent Claim
21 words
The method of claim 1 wherein the initiator is a thermal initiator and the initiating agent is a change in temperature.
Claim 11
Dependent Claim
23 words
The method of claim 1 wherein the free-radical polymerizable substituents are selected from the group of macromers containing two or more acrylate groups.
Claim 12
Dependent Claim
18 words
The method of claim 1 wherein the gel is prepared from macromers comprising an acrylate terminated poly(ethylene glycol).
Claim 13
Dependent Claim
53 words
The method of claim 1 wherein the polymerization initiator is selected from the group consisting of an eosin dye, a substituted eosin dye, riboflavin, acetophenone, a substituted acetophenone, a fluoroscein dye, a substituted fluoroscein dye, camphorquinone, rose bengal, methylene green, methylene blue, eosin Y, ethyl eosin, acridine orange, xanthine dye, and thioxanthine dyes.
Claim 14
Dependent Claim
20 words
The method of claim 1 wherein the polymerization initiator is selected from the group consisting of erythrosin, phloxime, and thionine.
Claim 15
Dependent Claim
13 words
The method of claim 5 wherein the catalyst or accelerator is an amine.
Claim 16
Dependent Claim
35 words
The method of claim 14 wherein the amine is selected from the group consisting of triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, dibenzyl amine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylene-diamine, lysine, ornithine, histidine and arginine.
Claim 17
Dependent Claim
20 words
The method of claim 1 wherein polymerization is initiation by light having a wavelength of between 320 and 800 nm.
Claim 18
Dependent Claim
19 words
The method of claim 16 or 2 wherein the light has a wavelength of 514 nm or 365 nm.
Claim 19
Dependent Claim
56 words
The method of claim 2, wherein the mammalian cell, mammalian cell aggregate, or mammalian tissue is contacted with a solution of a light sensitive photoinitiator to allow binding of the photoinitiator to the mammalian cell, mammalian cell aggregate, or mammalian tissue and the unbound initiator is removed prior to contacting it with the polymer or oligomer.
Claim 20
Dependent Claim
35 words
The method of claim 18 wherein the unbound initiator is removed by dilution with the macromer solution such that polymerization occurs only at the surface of the mammalian cell, mammalian cell aggregate, or mammalian tissue.
Claim 21
Dependent Claim
14 words
The method of claim 1, wherein the macromer solution is shaped and then polymerized.
Claim 22
Dependent Claim
12 words
The method of claim 1 wherein the gel contains a supporting structure.
Claim 23
Dependent Claim
24 words
The method of claim 1 wherein the polymer is selected and the polymerization is controlled to produce a desired permeability around the encapsulated material.
Claim 24
Dependent Claim
18 words
The method of claim 1 wherein polymerization of the macromer solution adheres tissue to other tissue or cells.
Claim 25
Dependent Claim
16 words
The method of claim 2 wherein biologically active material is encapsulated with the cells or tissue.
Claim 26
Dependent Claim
29 words
The method of claim 1, wherein a photopolymerizable polycation is preadsorbed to the molecule or material being encapsulated to increase attachment of the gel to the molecule or material.
Claim 27
Dependent Claim
31 words
The method of claim 1 wherein the macromer solution is applied to a tissue lumen and then polymerized to form a coating or support on the surface of the tissue lumen.
Claim 28
Independent Claim
102 words
A method for the preparation of a biocompatible substrate comprising: a) mixing (i) a water soluble biocompatible macromer comprising at least two free radical-polymerizable substituents, wherein the macromer is non-toxic and has a molecular weight of at least 400, (ii) a biocompatible substrate for mammalian cells, cell aggregates and cell tissue and (iii) a non-toxic free radical polymerization initiator selected from the group consisting of visible light or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free radical initiators, benzoyl peroxide, potassium persulfate and ammonium persulfate; and b) exposing the mixture to an activating agent to cause polymerization of the macromers.
Claim 29
Independent Claim
102 words
A method for the preparation of a biocompatible substrate comprising: a) mixing (i) a water soluble biocompatible macromer comprising at least two free radical-polymerizable substituents, wherein the macromer is non-toxic and has a molecular weight of at least 400, (ii) a biocompatible substrate for mammalian cells, cell aggregates and cell tissue and (iii) a non-toxic free radical polymerization initiator selected from the group consisting of visible light or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free radical initiators, benzoyl peroxide, potassium persulfate and ammonium persulfate; and b) exposing the mixture to an activating agent to cause polymerization of the macromers.
Claim 30
Dependent Claim
16 words
The method of claim 27 wherein a catalyst or accelerator is added in the mixing step.
Claim 31
Dependent Claim
24 words
The method of claim 27 wherein the substrate is selected from the group consisting of microspheres, membranes, woven matrices, porous matrices and prosthetic implants.
Claim 32
Dependent Claim
27 words
The method of claim 27, wherein the substrate is treated with an initiator, the unbound initiator is removed, the macromer is applied to the substrate and polymerized.
Claim 33
Independent Claim
54 words
A method for applying a polymeric coating to mammalian tissue or cells comprising applying a photoinitiator to the cells or tissue, removing unbound photoinitiator, applying a solution of water soluble macromer comprising at least two free radical-polymerizable substituents to the cells or tissue, and exposing the solution to visible or long wavelength ultraviolet light.
Claim 34
Independent Claim
54 words
A method for applying a polymeric coating to mammalian tissue or cells comprising applying a photoinitiator to the cells or tissue, removing unbound photoinitiator, applying a solution of water soluble macromer comprising at least two free radical-polymerizable substituents to the cells or tissue, and exposing the solution to visible or long wavelength ultraviolet light.
References Cited (Backward Citations)
US3960150A
Cited
US3981303A
Cited
US3986510A
Cited
US3993071A
Cited
US4450150A
Cited
US4193845A
Cited
US4194066A
Cited
US4076800A
Cited
US4226938A
Cited
US4195129A
Cited
US4272617A
Cited
US4321117A
Cited
US4411754A
Cited
US4329332A
Cited
US4283325A
Cited
US4295762A
Cited
US4352883A
Cited
US4391909A
Cited
US4409331A
Cited
US4298002A
Cited
US4376839A
Cited
US4359483A
Cited
EP0038172A2
Cited
US4376059A
Cited
US4729904A
Cited
US4590068A
Cited
US5106743A
Cited
US4446261A
Cited
US4829101A
Cited
US4434150A
Cited
US4647536A
Cited
US4526938A
Cited
US4942035A
Cited
US4806355A
Cited
US4689293A
Cited
US4652443A
Cited
US4511478A
Cited
US4605622A
Cited
US4563489A
Cited
US4663286A
Cited
US4749620A
Cited
US4744933A
Cited
US4774178A
Cited
US4745160A
Cited
JPS6132271A
Cited
US4637931A
Cited
US4950596A
Cited
EP0195304A2
Cited
US4822535A
Cited
US4741337A
Cited
US4931279A
Cited
US4889722A
Cited
US5160745A
Cited
US4829098A
Cited
US4716203A
Cited
US4957744A
Cited
US5037656A
Cited
US4913903A
Cited
US5288500A
Cited
US4826945A
Cited
US4804691A
Cited
US5185408A
Cited
US4916193A
Cited
US4888413A
Cited
US5066376A
Cited
US5268182A
Cited
US4925677A
Cited
US4938763A
Cited
US4938763B1
Cited
US5278202A
Cited
US5278201A
Cited
US5149416A
Cited
US5145906A
Cited
US5271961A
Cited
JPH03184555A
Cited
WO1991010425A1
Cited
US5183690A
Cited
US5219564A
Cited
US5149543A
Cited
US5410016A
Cited
US5109083A
Cited
US5153002A
Cited
US5271901A
Cited
WO1993009176A2
Cited
WO1993017669A1
Cited
US5567435A
Cited
WO1993021266A1
Cited
US5334640A
Cited
US5573934A
Cited
US5209849A
Cited
US5286495A
Cited
US5432210A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-01-11 | 2002-07-13 | 2003-01-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-01-11 | 2006-07-13 | 2007-01-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-01-11 | 2010-07-13 | 2011-01-12 | $7700.00 | Window Closed / Lapsed |